Patterns of Metabolic Progression to Type 1 Diabetes in the Diabetes Prevention Trial–Type 1

Abstract

These data indicate that over a period of at least 2 years, glucose tolerance gradually deteriorates as stimulated C-peptide levels slowly decline in a substantial number of individuals who develop type 1 diabetes. However, fasting C-peptide levels are maintained, even at diagnosis.